Entity Common Stock, Shares Outstanding of Aquestive Therapeutics, Inc. from 31 Aug 2018 to 02 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aquestive Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2018 to 02 Mar 2026.
  • Aquestive Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 02 Mar 2026 was 122,045,049, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 122,045,049 +23,173,680 +23% 02 Mar 2026 10-K 04 Mar 2026 2025 FY
Q3 2025 122,003,113 +30,824,920 +34% 03 Nov 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 99,723,635 +8,663,875 +9.5% 07 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 98,871,369 +25,570,168 +35% 03 Mar 2025 10-K 05 Mar 2025 2024 FY
Q3 2024 91,178,193 +24,410,910 +37% 01 Nov 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 91,059,760 +29,333,092 +48% 02 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 73,301,201 +17,378,840 +31% 01 Mar 2024 10-K 05 Mar 2024 2023 FY
Q3 2023 66,767,283 +12,611,269 +23% 03 Nov 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 61,726,668 +8,376,014 +16% 04 Aug 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 55,922,361 +14,009,409 +33% 26 Apr 2023 10-Q 02 May 2023 2023 Q1
Q3 2022 54,156,014 +13,991,986 +35% 24 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 53,350,654 +14,464,189 +37% 25 Jul 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 41,912,952 +5,698,983 +16% 25 Apr 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 40,164,028 +6,544,232 +19% 25 Oct 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 38,886,465 +5,266,669 +16% 26 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 36,213,969 +2,631,735 +7.8% 05 Mar 2021 10-K 09 Mar 2021 2020 FY
Q3 2020 33,619,796 +8,576,832 +34% 02 Nov 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 33,619,796 +8,593,203 +34% 31 Jul 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 33,582,234 +8,607,227 +34% 06 Mar 2020 10-K 11 Mar 2020 2019 FY
Q3 2019 25,042,964 +101,113 +0.4% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 25,026,593 02 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 24,975,007 08 Mar 2019 10-K 14 Mar 2019 2018 FY
Q3 2018 24,941,851 31 Aug 2018 10-Q 04 Sep 2018 2018 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.